Evidence map›Paper›PMID 18562530›Full record

ArticleJournal of virology2008

Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.

Toshiyuki Miura, Mark A Brockman, Chanson J Brumme, Zabrina L Brumme, Jonathan M Carlson, Florencia Pereyra, Alicja Trocha, Marylyn M Addo, Brian L Block, Alissa C Rothchild and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 129 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Korean Red Ginseng increases defectiveJournal of ginseng research · 2019
    Article
  9. Article
  10. Article
  11. Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.Journal of acquired immune deficiency syndromes (1999) · 2018
    Article
  12. Article
  13. High HIV-1 RNA Among Newly Diagnosed People in Botswana.AIDS research and human retroviruses · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Genetic defects in theJournal of ginseng research · 2017
    Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Toshiyuki MiuraPartners AIDS Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
Mark A Brockman
Chanson J Brumme
Zabrina L Brumme
Jonathan M Carlson
Florencia Pereyra
Alicja Trocha
Marylyn M Addo
Brian L Block
Alissa C Rothchild
Brett M Baker
Theresa Flynn
Arne Schneidewind
Bin Li
Yaoyu E Wang
David Heckerman
Todd M Allen
Bruce D Walker
Massachusetts General Hospital · USHarvard University · USHoward Hughes Medical Institute · USMicrosoft (United States) · USUniversity of Washington · US

Funding

INHIBITION OF HIV1 REPLICATION BY CYTOTOXIC LYMPHOCYTESR01AI030914 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1991 to 2013
$4.2M
Acute CTL Escape and Viral Variation in HIVR01AI054178 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2003 to 2007
$2.1M
HIV-1-SPECIFIC T CELL CLONESR01AI028568 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1989 to 2008
$1.9M
HIV-1 SPECIFIC T CELL CLONESR37AI028568 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1994 to 2003
$1.6M
Impact of CTL Escape Mutations on HIV-1 Replicative FitnessR56AI054178 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2009 to 2009
$442k
NIAID NIH HHS AI28568NIAID NIH HHS AI30914NIAID NIH HHS R01 AI028568NIAID NIH HHS R01 AI030914NIAID NIH HHS R01 AI054178NIAID NIH HHS R37 AI028568NIAID NIH HHS R56 AI054178
6 · The paper itself

Abstract

Despite reports of viral genetic defects in persons who control human immunodeficiency virus type 1 (HIV-1) in the absence of antiviral therapy, the extent to which such defects contribute to the long-term containment of viremia is not known. Most previous studies examining for such defects have involved small numbers of subjects, primarily focused on subjects expressing HLA-B57, or have examined single viral genes, and they have focused on cellular proviral DNA rather than plasma viral RNA sequences. Here, we attempted viral sequencing from 95 HIV-1 elite controllers (EC) who maintained plasma viral loads of <50 RNA copies/ml in the absence of therapy, the majority of whom did not express HLA-B57. HIV-1 gene fragments were obtained from 94% (89/95) of the EC, and plasma viral sequences were obtained from 78% (61/78), the latter indicating the presence of replicating virus in the majority of EC. Of 63 persons for whom nef was sequenced, only three cases of nef deletions were identified, and gross genetic defects were rarely observed in other HIV-1 coding genes. In a codon-by-codon comparison between EC and persons with progressive infection, correcting for HLA bias and coevolving secondary mutations, a significant difference was observed at only three codons in Gag, all three of which represented the historic population consensus amino acid at the time of infection. These results indicate that the spontaneous control of HIV replication is not attributable to shared viral genetic defects or shared viral polymorphisms.

Indexed as

Amino Acid SequenceBase SequenceCodonCohort StudiesGene Products, gagGene Products, nefGenome, ViralHIV-1HumansPhylogenyRNA, ViralSequence Analysis, DNASequence Analysis, ProteinSequence Analysis, RNASequence DeletionViral LoadCodonGene Products, gagGene Products, nefRNA, Viral

Identifiers

PMID18562530
PMCPMC2519665
OpenAlexW2082738868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.